chr20-13167505-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018327.4(SPTLC3):​c.*2638C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.468 in 151,938 control chromosomes in the GnomAD database, including 16,816 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 16816 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SPTLC3
NM_018327.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.227

Publications

8 publications found
Variant links:
Genes affected
SPTLC3 (HGNC:16253): (serine palmitoyltransferase long chain base subunit 3) This gene encodes a subunit of the serine palmitoyltransferase complex which catalyzes the rate-limiting step in sphingolipid biosynthesis. This subunit metabolizes lauroyl- and myristoyl-CoA and generates C14 and C16-sphingoid bases. [provided by RefSeq, Mar 2017]
TASP1 (HGNC:15859): (taspase 1) This gene encodes an endopeptidase that cleaves specific substrates following aspartate residues. The encoded protein undergoes posttranslational autoproteolytic processing to generate alpha and beta subunits, which reassemble into the active alpha2-beta2 heterotetramer. It is required to cleave MLL, a protein required for the maintenance of HOX gene expression, and TFIIA, a basal transcription factor. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
TASP1 Gene-Disease associations (from GenCC):
  • Suleiman-El-Hattab syndrome
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTLC3NM_018327.4 linkc.*2638C>G 3_prime_UTR_variant Exon 12 of 12 ENST00000399002.7 NP_060797.2 Q9NUV7-1
SPTLC3NM_001349945.2 linkc.*2638C>G 3_prime_UTR_variant Exon 13 of 13 NP_001336874.1
SPTLC3XM_011529280.2 linkc.*2638C>G 3_prime_UTR_variant Exon 9 of 9 XP_011527582.1
TASP1XR_001754319.3 linkn.1370-62248G>C intron_variant Intron 14 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTLC3ENST00000399002.7 linkc.*2638C>G 3_prime_UTR_variant Exon 12 of 12 1 NM_018327.4 ENSP00000381968.2 Q9NUV7-1

Frequencies

GnomAD3 genomes
AF:
0.468
AC:
71066
AN:
151820
Hom.:
16788
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.440
Gnomad AMI
AF:
0.565
Gnomad AMR
AF:
0.501
Gnomad ASJ
AF:
0.447
Gnomad EAS
AF:
0.629
Gnomad SAS
AF:
0.598
Gnomad FIN
AF:
0.452
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.459
Gnomad OTH
AF:
0.459
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
4
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.468
AC:
71149
AN:
151938
Hom.:
16816
Cov.:
32
AF XY:
0.474
AC XY:
35191
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.441
AC:
18265
AN:
41416
American (AMR)
AF:
0.501
AC:
7652
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.447
AC:
1548
AN:
3466
East Asian (EAS)
AF:
0.629
AC:
3253
AN:
5172
South Asian (SAS)
AF:
0.599
AC:
2886
AN:
4816
European-Finnish (FIN)
AF:
0.452
AC:
4764
AN:
10548
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.459
AC:
31190
AN:
67944
Other (OTH)
AF:
0.460
AC:
970
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1975
3950
5925
7900
9875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.460
Hom.:
1998
Bravo
AF:
0.471
Asia WGS
AF:
0.649
AC:
2256
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.78
DANN
Benign
0.60
PhyloP100
-0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2144134; hg19: chr20-13148152; API